Polina Weitzenfeld
Tel Aviv, TA, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Fc-optimized CD40 agonistic antibody elicits tertiary lymphoid structure formation and systemic antitumor immunity in metastatic cancer.
Journal: Cancer cell
Published: October 10, 2024
Intratumoral Fc-optimized agonistic CD40 antibody induces tumor rejection and systemic antitumor immunity in patients with metastatic cancer.
Journal: Research square
Published: June 17, 2024
Siglecs-7/9 function as inhibitory immune checkpoints in vivo and can be targeted to enhance therapeutic antitumor immunity.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 22, 2021
Antibodies targeting sialyl Lewis A mediate tumor clearance through distinct effector pathways.
Journal: The Journal of clinical investigation
Published: February 26, 2019
Microenvironmental networks promote tumor heterogeneity and enrich for metastatic cancer stem-like cells in Luminal-A breast tumor cells.
Journal: Oncotarget
Published: April 09, 2016
Chemokine axes in breast cancer: factors of the tumor microenvironment reshape the CCR7-driven metastatic spread of luminal-A breast tumors.
Journal: Journal of leukocyte biology
Published: August 24, 2015
Progression of luminal breast tumors is promoted by ménage à trois between the inflammatory cytokine TNFα and the hormonal and growth-supporting arms of the tumor microenvironment.
Journal: Mediators of inflammation
Published: August 21, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026